Inhibition of immunoglobulin E synthesis through FcγRII (CD32) by a mechanism independent of B-cell receptor co-cross-linking

Immunology

Volumn 115, Issue 3, 2005, Pages 407-415

  Horejs Hoeck, Jutta ^a,b   Hren, Andrea ^b   Mudde, Geert C ^b,c   Woisetschläger, Maximilian ^b,d  

^a UNIVERSITY OF SALZBURG   (Austria)

^b Novartis Institutes for BioMedical Research Vienna   (Austria)

^c Igeneon AG   (Austria)

^d Novartis Institutes Biomedical Research Vienna   (Austria)

Author keywords

Allergy; B lymphocytes; CD32; IgE; Isotype switching

Indexed keywords

B LYMPHOCYTE RECEPTOR; CD32 ANTIGEN; FC RECEPTOR; FC RECEPTOR II; IMMUNOGLOBULIN E; INTERLEUKIN 4; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE ACTIVATION; CELL STIMULATION; CONTROLLED STUDY; CROSS LINKING; DOWN REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIBODY SPECIFICITY; ANTIGENS, CD40; B-LYMPHOCYTES; CELL DIVISION; CELL LINE; CELLS, CULTURED; DOWN-REGULATION; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN ISOTYPES; IMMUNOGLOBULIN M; INTERLEUKIN-4; LIGANDS; RECEPTORS, ANTIGEN, B-CELL; RECEPTORS, IGG; TONSIL; TRANSCRIPTION, GENETIC;

EID: 21244486363     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2005.02162.x     Document Type: Article

References (43)

1. Bheekha Escura R, Wasserbauer E, Hammerschmid F, Pearce A, Kidd P, Mudde GC. Regulation and targeting of T-cell immune responses by IgE and IgG antibodies. Immunology 1995; 86:343-50.
2. Mudde GC, Bheekha R, Bruijnzeel-Koomen CA. Consequences of IgE/CD23-mediated antigen presentation in allergy. Immunol Today 1995; 16:380-3.
3. Mudde GC, Reischul IG, Corvaia N, Hren A, Poellabauer EM. Antigen presentation in allergic sensitization. Immunol Cell Biol 1996; 74:167-73.
4. Daeron M. Fc receptor biology. Annu Rev Immunol 1997; 15:203-34.
5. Ravetch JV, Kinet JP. Fc receptors. Annu Rev Immunol 1991; 9:457-92.
6. Qiu WQ, de Bruin D, Brownstein BH, Pearse R, Ravetch JV. Organization of the human and mouse low-affinity Fc gamma R genes: duplication and recombination. Science 1990; 248:732-5.
7. Warmerdam PA, van den Herik-Oudijk IE, Parren PW, Westerdaal NA, van de Winkel JG, Capel PJ. Interaction of a human Fc gamma RIIb1 (CD32) isoform with murine and human IgG subclasses. Int Immunol 1993; 5:239-47.
8. Hibbs ML, Bonadonna L, Scott BM, McKenzie IF, Hogarth PM. Molecular cloning of a human immunoglobulin G Fc receptor. Proc Natl Acad Sci USA 1988; 85:2240-4.
9. Brooks DG, Qiu WQ, Luster AD, Ravetch JV. Structure and expression of human IgG FcRII (CD32). Functional heterogeneity is encoded by the alternatively spliced products of multiple genes. J Exp Med 1989; 170:1369-85.
10. Sarmay G, Rozsnyay Z, Koncz G, Danilkovich A, Gergely J. The alternative splicing of human Fc gamma RII mRNA is regulated by activation of B cells with mIgM cross-linking, interleukin-4, or phorbolester. Eur J Immunol 1995; 25:262-8.
11. Van Den Herik-Oudijk IE, Westerdaal NA, Henriquez NV, Capel PJ, Van De Winkel JG. Functional analysis of human Fc gamma RII (CD32) isoforms expressed in B lymphocytes. J Immunol 1994; 152:574-85.
12. Uhr JW, Moller G. Regulatory effect of antibody on the immune response. Adv Immunol 1968; 8:81-127.
13. Chan PL, Sinclair NR. Regulation of the immune response. V. An analysis of the function of the Fc portion of antibody in suppression of an immune response with respect to interaction with components of the lymphoid system. Immunology 1971; 21: 967-81.
14. Vivier E, Daeron M. Immunoreceptor tyrosine-based inhibition motifs. Immunol Today 1997; 18:286-91.
15. Cambier JC. Inhibitory receptors abound? Proc Natl Acad Sci USA 1997; 94:5993-5.
16. Ono M, Okada H, Holland S, Yanagi S, Kurosaki T, Ravetch JV. Deletion of SHIP or SHP-1 reveals two distinct pathways for inhibitory signaling. Cell 1997; 90:293-301.
17. Pearse RN, Kawabe T, Bolland S, Guinamard R, Kurosaki T, Ravetch JV. SHIP recruitment attenuates Fc gamma RIIB-induced B cell apoptosis. Immunity 1999; 10:753-60.
18. Van Kooten C, Banchereau J. CD40-CD40 ligand: a multifunctional receptor-ligand pair. Adv Immunol 1996; 61:1-77.
19. Banchereau J, de Paoli P, Valle A, Garcia E, Roussel F. Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science 1991; 251:70-2.
20. Gauchat JF, Aversa G, Gascan H, de Vries JE. Modulation of IL-4 induced germline epsilon RNA synthesis in human B cells by tumor necrosis factor-alpha, anti-CD40 monoclonal antibodies or transforming growth factor-beta correlates with levels of IgE production. Int Immunol 1992; 4:397-406.
21. Coffman RL, Lebman DA, Rothman P. Mechanism and regulation of immunoglobulin isotype switching. Adv Immunol 1993; 54:229-70.
22. Stavnezer J. Immunoglobulin class switching. Curr Opin Immunol 1996; 8:199-205.
23. Thompson PA, Jelinek DF, Lipsky PE. Regulation of human B cell proliferation by prostaglandin E2. J Immunol 1984; 133:2446-53.
24. van Reijsen FC, Bruijnzeel-Koomen CA, Kalthoff FS, Maggi E, Romagnani S, Westland JK, Mudde GC. Skin-derived aeroallergen-specific T-cell clones of Th2 phenotype in patients with atopic dermatitis. J Allergy Clin Immunol 1992; 90:184-93.
25. Berger M, Albrecht B, Berces A, Ettmayer P, Neruda W, Woisetschläger M. S(+)-4-(1-Phenylethylamino) quinazolines as inhibitors of human immunoglobuline E synthesis: potency is dictated by stereochemistry and atomic point charges at N-1. J Med Chem 2001; 44:3031.
26. 2+ mobilization is integrated by CD19 dephosphorylation. Immunity 1997; 7:49-58.
27. Doody GM, Dempsey PW, Fearon DT. Activation of B lymphocytes, integrating signals from CD19, CD22 and Fc gamma RIIb1. Curr Opin Immunol 1996; 8:378-82.
28. Punnonen J, Cocks BG, Carballido JM, Bennett B, Peterson D, Aversa G, de Vries JE. Soluble and membrane-bound forms of signaling lymphocytic activation molecule (SLAM) induce proliferation and Ig synthesis by activated human B lymphocytes. J Exp Med 1997; 185:993-1004.
29. Lane P, Brocker T, Hubele S, Padovan E, Lanzavecchia A, McConnell F. Soluble CD40 ligand can replace the normal T cell-derived CD40 ligand signal to B cells in T cell-dependent activation. J Exp Med 1993; 177:1209-13.
30. Kenter AL, Watson JV. Cell cycle kinetics model of LPS-stimulated spleen cells correlates switch region rearrangements with S phase. J Immunol Methods 1987; 97:111-7.
31. Geha RS, Jabara HH, Brodeur SR. The regulation of immunoglobulin E class-switch recombination. Nat Rev 2003; 3:721.
32. O'Rourke L, Tooze R, Fearon DT. Co-receptors of B lymphocytes. Curr Opin Immunol 1997; 9:324-9.
33. Zhuang Q, Bisotto S, Fixman ED, Mazer B. Suppression of IL-4- and CD40-induced B-lymphocyte activation by intravenous immunoglobulin is not mediated through the inhibitory IgG receptor FcgammaRIIb. J Allergy Clin Immunol 2002; 110:480-3.
34. Uher F, Lamers MC, Dickler HB. Antigen-antibody complexes bound to B-lymphocyte Fc gamma receptors regulate B-lymphocyte differentiation. Cell Immunol 1985; 95:368-79.
35. Uher F, Dickler HB. Cooperativity between B lymphocyte membrane molecules, independent ligand occupancy and cross-linking of antigen receptors and Fc gamma receptors down-regulates B lymphocyte function. J Immunol 1986; 137:3124-9.
36. Sigman K, Ghibu F, Sommerville W, Toledano BJ, Bastein Y, Cameron L, Hamid QA, Mazer B. Intravenous immunoglobulin inhibits IgE production in human B lymphocytes. J Allergy Clin Immunol 1998; 102:421-7.
37. Ravanel K, Castelle C, Defrance T, Wild TF, Charron D, Lotteau V, Rabourdin-Combe C. Measles virus nucleocapsid protein binds to FcgammaRII and inhibits human B cell antibody production. J Exp Med 1997; 186:269-78.
38. te Velde AA, Huijbens RJ, Heije K, de Vries JE, Figdor CG. Interleukin-4 (IL-4) inhibits secretion of IL-1 beta, tumor necrosis factor alpha, and IL-6 by human monocytes. Blood 1990; 76:1392-7.
39. + T helper subsets. J Immunol 1989; 143:2133-41.
40. Laszlo G, Dickler HB. IL-4 induces loss of B lymphocyte Fc gamma R II ligand binding capacity. J Immunol 1988; 141:3416-21.
41. Reth M. Antigen receptor tail clue. Nature 1989; 338:383-4.
42. Machiels JJ, Somville MA, Lebrun PM, Lebecque SJ, Jacquemin MG, Saint-Remy JM. Allergic bronchial asthma due to Dermatophagoides pteronyssinus hypersensitivity can be efficiently treated by inoculation of allergen-antibody complexes. J Clin Invest 1990; 85:1024-35.
43. Machiels JJ, Lebrun PM, Jacquemin MG, Saint-Remy JM. Significant reduction of nonspecific bronchial reactivity in patients with Dermatophagoides pteronyssinus-sensitive allergic asthma under therapy with allergen-antibody complexes. Am Rev Respir Dis 1993; 147:1407-12.